Analysis of Exalenz Bioscience manpower and management performance can provide insight into Exalenz Bioscience stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Exalenz Bioscience future performance. Additionally see Investing Opportunities.
Exalenz Bioscience Management Effectiveness
The company has return on total asset (ROA) of (29.93) % which means that it has lost $29.93 on every $100 spent on asset. This is way below average.
The company has Profit Margin (PM) of (40.19) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (39.94) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.4.
The output start index for this execution was zero with a total number of output elements of seventeen. Exalenz Bioscience Price Series Summation is a cross summation of Exalenz Bioscience price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.
Exalenz Bioscience employes about 17 people. The company is managed by 22 executives with total tenure of roughly 110 years, averanging almost 5.0 years of service per executive having 0.0 employee per reported executive.
Exalenz BioscienceManpower Efficiency
Return on Exalenz Bioscience Manpower
Revenue Per Employee
Revenue Per Executive
Net Loss Per Employee
Net Loss Per Executive
Working Capital Per Employee
Working Capital Per Executive
Additionally see Investing Opportunities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.